Vol. 51 No. 7 (2012): Acta Oncologica

Articles

• Outcome of first line systemic treatment in elderly compared to younger patients with metastatic colorectal cancer: A retrospective analysis of the CAIRO and CAIRO2 studies of the Dutch Colorectal Cancer Group (DCCG)

  Sabine Venderbosch, Joan Doornebal, Steven Teerenstra, Wim Lemmens, Cornelis J. A. Punt, Miriam Koopman

  831-839

  Published: 2012-09-01

  • PDF

• Incidence and risk of pulmonary toxicity in patients treated with mTOR inhibitors for malignancy. A meta-analysis of published trials

  Roberto Iacovelli, Antonella Palazzo, Silvia Mezi, Federica Morano, Giuseppe Naso, Enrico Cortesi

  873-879

  Published: 2012-09-01

  • PDF

• Survival of cervical cancer patients in Germany in the early 21st century: A period analysis by age, histology, and stage

  Tianhui Chen, Lina Jansen, Adam Gondos, Katharina Emrich, Bernd Holleczek, Sabine Luttmann, Annika Waldmann, Hermann Brenner

  915-921

  Published: 2012-09-01

  • PDF

• Epidermal growth factor receptor mutations in synchronous recurrent lung cancer in an 82-year-old woman. A case story

  Charlotte Kristiansen, Karen Ege Olsen, Niels Christian Hansen, Karin Holmskov Hansen, Olfred Hansen

  948-949

  Published: 2012-09-01

  • PDF

• A note on Ostericum koreanum

  Christophe Wiart

  959

  Published: 2012-09-01

  • PDF

• Palliative chemotherapy in elderly patients with metastatic colorectal cancer: Do we know how it should be used?

  Halfdan Sorbye

  819-821

  Published: 2012-09-01

  • PDF

• Randomized phase II trial of S-1 and cisplatin versus gemcitabine and cisplatin in patients with advanced biliary tract adenocarcinoma

  Myoung Joo Kang, Jae-Lyun Lee, Tae Won Kim, Sung Sook Lee, Shin Ahn, Do Hyun Park, Sang Soo Lee, Dong Wan Seo, Sung Koo Lee, Myung-Hwan Kim

  860-866

  Published: 2012-09-01

  • PDF

• Outcomes of cancer patients after unplanned admission to general intensive care units

  Monique M. E. M. Bos, Nicolette F. de Keizer, Iwan A. Meynaar, Ferishta Bakhshi-Raiez, Evert de Jonge

  897-905

  Published: 2012-09-01

  • PDF

• Marked response to both S-1 and pemetrexed in a patient with echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase-positive lung adenocarcinoma

  Hiroyasu Kaneda, Isamu Okamoto, Kazuko Sakai, Junko Tanizaki, Masayuki Takeda, Kazuto Nishio, Kazuhiko Nakagawa

  942-944

  Published: 2012-09-01

  • PDF

• Intrathecal trastuzumab: dose matters

  Silvia Hofer, Karin Mengele, Hans Joachim Stemmler, Manfred Schmitt, Bernhard Pestalozzi

  955-956

  Published: 2012-09-01

  • PDF

• Cost identification of Nordic FLIRI, Nordic FLOX, XELIRI and XELOX in first-line treatment of advanced colorectal cancer in Sweden – A clinical practice model approach

  Karin Pettersson, Göran Carlsson, Christoffer Holmberg, Sofia Kälvemark Sporrong

  840-848

  Published: 2012-09-01

  • PDF

• Data quality at the Icelandic Cancer Registry: Comparability, validity, timeliness and completeness

  Lara Gudrun Sigurdardottir, Jon Gunnlaugur Jonasson, Sigrun Stefansdottir, Anna Jonsdottir, Gudridur Helga Olafsdottir, Elinborg Jona Olafsdottir, Laufey Tryggvadottir

  880-889

  Published: 2012-09-01

  • PDF

• Cancer in adolescents and young adults (15–29 years): A population-based study in the Netherlands 1989–2009

  Katja K. Aben, Carlijn van Gaal, Nienke A. van Gils, Winette T. van der Graaf, Gerhard A. Zielhuis

  922-933

  Published: 2012-09-01

  • PDF

• Cancer diagnoses in Iraqi refugees

  Farrah J. Mateen, Marco Carone, Huda Al-Saedy, Sayre Nyce, Timothy Mutuerandu, Jad Ghosn, Aminah Jatoi

  950-951

  Published: 2012-09-01

  • PDF

• Doctoral Dissertation: Rajaraman Swaminathan: An evaluation of survival of cancer patients based on registry data from low or medium resource countries

  Rajaraman Swaminathan

  960

  Published: 2012-09-01

  • PDF

• Targeting endoplasmic reticulum signaling pathways in cancer

  Fabio Martinon

  822-830

  Published: 2012-09-01

  • PDF

• Phase II study of combined chemotherapy with irinotecan and S-1 (IRIS) plus bevacizumab in patients with inoperable recurrent or advanced colorectal cancer

  Yoshito Komatsu, Satoshi Yuki, Susumu Sogabe, Hiraku Fukushima, Hiroshi Nakatsumi, Yoshimitsu Kobayashi, Ichiro Iwanaga, Michio Nakamura, Kazuteru Hatanaka, Takuto Miyagishima, Mineo Kudo, Masaki Munakata, Takashi Meguro, Miki Tateyama, Yuh Sakata

  867-872

  Published: 2012-09-01

  • PDF

• Survival of stomach and esophagus cancer patients in Germany in the early 21st century

  Eva Hiripi, Lina Jansen, Adam Gondos, Katharina Emrich, Bernd Holleczek, Alexander Katalinic, Sabine Luttmann, Alice Nennecke, Hermann Brenner

  906-914

  Published: 2012-09-01

  • PDF

• Severe dermatologic adverse reactions after exposure to lenalidomide in multiple myeloma patients with a positive HLA-DRB1*1501 and HLA-DQB1*0602

  Giuseppa Penna, Alessandro Allegra, Giuseppa Romeo, Andrea Alonci, Antonino Cannavò, Sabina Russo, Arianna D'Angelo, Annamaria Petrungaro, Caterina Musolino

  944-947

  Published: 2012-09-01

  • PDF

• Thirty year trends in testicular cancer mortality in Europe: Gaps persist between the East and West

  Ariana Znaor, Freddie Bray

  956-958

  Published: 2012-09-01

  • PDF

• Evaluation of predictive markers for patients with advanced colorectal cancer

  Per Byström, Åke Berglund, Peter Nygren, Lisa Wernroth, Birgitta Johansson, Anders Larsson, Bengt Glimelius

  849-859

  Published: 2012-09-01

  • PDF

• Non-inferiority trials in breast and non-small cell lung cancer: Choice of non-inferiority margins and other statistical aspects

  Everardo D. Saad, Marc Buyse

  890-896

  Published: 2012-09-01

  • PDF

• Breast reconstruction in patients with personal and family history of breast cancer undergoing contralateral prophylactic mastectomy, a 10-year experience

  Dmytro Unukovych, Kerstin Sandelin, Marie Wickman, Brita Arver, Hemming Johansson, Yvonne Brandberg, Annelie Liljegren

  934-941

  Published: 2012-09-01

  • PDF

• Induction cisplatin-based chemotherapy and following radiotherapy in locally advanced basal cell carcinoma of the skin

  Jana Jaal, Kadri Putnik

  952-954

  Published: 2012-09-01

  • PDF